ConductScience.org, home

Paper7150779

Estrogen and progesterone receptors: correlation of response rates, site and timing of receptor analysis.

Stewart J and 3 others. Breast Cancer Res Treat, 1982. Cited by 32 papers, by iCite.

Cite this record

ConductScience Library. Estrogen and progesterone receptors: correlation of response rates, site and timing of receptor analysis. Papers, record 7150779. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7150779

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Estrogen and progesterone receptors: correlation of response rates, site and timing of receptor analysis.
PubMed
Journal
Breast Cancer Res Treat
PubMed
Year
1982
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
32
iCite
Relative citation ratio, by iCite
0.73
iCite
Revised in PubMed
2026-10-10
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Stewart JJ
2King RR
3Hayward JJ
4Rubens RR

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Breast NeoplasmsMajor topic
Receptors, EstrogenMajor topic
Receptors, ProgesteroneMajor topic
Aged
Castration
Cytosol
Female
Gonadal Steroid Hormones
Humans
Menopause
Middle Aged
Neoplasm Proteins
Phenotype

Source PubMed

Download CSV of topics

References13

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
17448733The value of estrogen and progesterone receptors in the treatment of breast cancer.Cancer1980https://conductscience.org/library/papers/7448733PubMed
2707701Estrogen receptor levels in multiple biopsies from patients with breast cancer.Am J Surg1978https://conductscience.org/library/papers/707701PubMed
37448727Analysis of estradiol and progesterone receptors in early and advanced breast tumors.Cancer1980https://conductscience.org/library/papers/7448727PubMed
4831755Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples.Br J Cancer1977https://conductscience.org/library/papers/831755PubMed
57448741The clinical value of multiple steroid receptor assays in breast cancer management.Cancer1980https://conductscience.org/library/papers/7448741PubMed
67448730Estrogen and progesterone receptors in the prediction of response of breast cancer to endocrine therapy.Cancer1980https://conductscience.org/library/papers/7448730PubMed
77448744Relationship between steroid receptors and response to endocrine therapy and cytotoxic chemotherapy in metastatic breast cancer.Cancer1980https://conductscience.org/library/papers/7448744PubMed
8856236Assessment of response to therapy in advanced breast cancer.Br J Cancer1977https://conductscience.org/library/papers/856236PubMed
9492228Special report. Steroid receptors in breast cancer.N Engl J Med1979https://conductscience.org/library/papers/492228PubMed
107448720Steroid receptors and response to endocrine ablations in women with metastatic cancer of the breast.Cancer1980https://conductscience.org/library/papers/7448720PubMed
11870169Estrogen receptor protein (ERP) in multiple tumor specimens from individual patients with breast cancer.Cancer1977https://conductscience.org/library/papers/870169PubMed
12168640Predicting response to endocrine therapy in human breast cancer: a hypothesis.Science1975https://conductscience.org/library/papers/168640PubMed
13684560Current use of steroid hormone receptor assays in the treatment of breast cancer.Surg Clin North Am1978https://conductscience.org/library/papers/684560PubMed

Download CSV of references

Cited by16

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 32 citations.

PMIDTitleJournalYearIn PapersSource
31698248Androgen Receptor Is a Non-canonical Inhibitor of Wild-Type and Mutant Estrogen Receptors in Hormone Receptor-Positive Breast Cancers.iScience2019https://conductscience.org/library/papers/31698248PubMed
28490933Prognostic and predictive value of low estrogen receptor expression in breast cancer.Curr Oncol2017https://conductscience.org/library/papers/28490933PubMed
28412963Posttranslationally modified progesterone receptors direct ligand-specific expression of breast cancer stem cell-associated gene programs.J Hematol Oncol2017https://conductscience.org/library/papers/28412963PubMed
27279236Estrogen Receptor-β and the Insulin-Like Growth Factor Axis as Potential Therapeutic Targets for Triple-Negative Breast Cancer.Crit Rev Oncog2015https://conductscience.org/library/papers/27279236PubMed
26989346Tamoxifen Action in ER-Negative Breast Cancer.Sign Transduct Insights2016https://conductscience.org/library/papers/26989346PubMed
25874233Biologic roles of estrogen receptor-β and insulin-like growth factor-2 in triple-negative breast cancer.Biomed Res Int2015https://conductscience.org/library/papers/25874233PubMed
24291072Tracking progesterone receptor-mediated actions in breast cancer.Pharmacol Ther2014https://conductscience.org/library/papers/24291072PubMed
17333340Letrozole in advanced breast cancer: the PO25 trial.Breast Cancer Res Treat2007https://conductscience.org/library/papers/17333340PubMed
8912543Immunohistochemical determination of oestrogen receptor: comparison of different methods of assessment of staining and correlation with clinical outcome of breast cancer patients.Br J Cancer1996https://conductscience.org/library/papers/8912543PubMed
7880722Loss of heterozygosity of the oestrogen receptor gene in breast cancer.Br J Cancer1995https://conductscience.org/library/papers/7880722PubMed
3966982The effect of oestrogen and progesterone receptors on recurrence and survival in patients with carcinoma of the breast.Br J Cancer1985https://conductscience.org/library/papers/3966982PubMed
3814476The clinical course of bone metastases from breast cancer.Br J Cancer1987https://conductscience.org/library/papers/3814476PubMed
3697513Response to endocrine therapy and breast cancer differentiation.Breast Cancer Res Treat1986https://conductscience.org/library/papers/3697513PubMed
3219274Prednisolone improves the response to primary endocrine treatment for advanced breast cancer.Br J Cancer1988https://conductscience.org/library/papers/3219274PubMed
2413929Prognostic value of estrogen receptors determined by radiochemical vs. histochemical methods in breast cancer.Breast Cancer Res Treat1985https://conductscience.org/library/papers/2413929PubMed
1534019Comparison of two oestrogen receptor assays in the prediction of the clinical course of patients with advanced breast cancer.Br J Cancer1992https://conductscience.org/library/papers/1534019PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ESR12099PubTator's text mininghttps://conductscience.org/library/genes/2099NCBI Gene
PGR5241PubTator's text mininghttps://conductscience.org/library/genes/5241NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7150779

GET https://conductscience.org/api/papers/v1/7150779/authors